Clinical Trial Update: Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy [NA]

View source ↗

Summary

A recruiting clinical trial aims to identify genetic, phenotypic, clinical, biological and histological factors that differentiate platinum-refractory ovarian c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Centre Jean Perrin | Conditions: Ovarian Cancer | NA | Status: RECRUITING